Steward Partners Investment Advisory’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,070
| Closed | -$210K | – | 4478 |
|
|
2025
Q4 | $210K | Sell |
2,070
-151
| -7% | -$12.1K | ﹤0.01% | 1907 |
|
|
2025
Q3 | $122K | Buy |
2,221
+833
| +60% | +$41.6K | ﹤0.01% | 2115 |
|
|
2025
Q2 | $73.8K | Sell |
1,388
-77
| -5% | -$3.91K | ﹤0.01% | 2279 |
|
|
2025
Q1 | $63.4K | Buy |
1,465
+41
| +3% | +$2.08K | ﹤0.01% | 2257 |
|
|
2024
Q4 | $80K | Buy |
1,424
+11
| +0.8% | +$685 | ﹤0.01% | 2094 |
|
|
2024
Q3 | $96.3K | Buy |
1,413
+151
| +12% | +$8.52K | ﹤0.01% | 1891 |
|
|
2024
Q2 | $53.3K | Sell |
1,262
-3,523
| -74% | -$194K | ﹤0.01% | 2073 |
|
|
2024
Q1 | $330K | Buy |
4,785
+154
| +3% | +$9.74K | ﹤0.01% | 1220 |
|
|
2023
Q4 | $343K | Buy |
4,631
+3,492
| +307% | +$229K | ﹤0.01% | 1162 |
|
|
2023
Q3 | $77.7K | Buy |
1,139
+30
| +3% | +$2.54K | ﹤0.01% | 1697 |
|
|
2023
Q2 | $104K | Sell |
1,109
-130
| -10% | -$10.1K | ﹤0.01% | 1566 |
|
|
2023
Q1 | $84K | Buy |
1,239
+216
| +21% | +$13.9K | ﹤0.01% | 1654 |
|
|
2022
Q4 | $50.6K | Buy |
1,023
+107
| +12% | +$4.37K | ﹤0.01% | 1834 |
|
|
2022
Q3 | $30K | Buy |
916
+249
| +37% | +$10.3K | ﹤0.01% | 2022 |
|
|
2022
Q2 | $26K | Buy |
667
+205
| +44% | +$11K | ﹤0.01% | 2106 |
|
|
2022
Q1 | $32K | Sell |
462
-3,164
| -87% | -$231K | ﹤0.01% | 2138 |
|
|
2021
Q4 | $282K | Buy |
3,626
+3,054
| +534% | +$270K | ﹤0.01% | 1169 |
|
|
2021
Q3 | $55K | Hold |
572
| – | – | ﹤0.01% | 1835 |
|
|
2021
Q2 | $71K | Sell |
572
-1,082
| -65% | -$129K | ﹤0.01% | 2704 |
|
|
2021
Q1 | $218K | Buy |
1,654
+1,048
| +173% | +$143K | ﹤0.01% | 1256 |
|
|
2020
Q4 | $80K | Buy |
606
+59
| +11% | +$7.13K | ﹤0.01% | 1461 |
|
|
2020
Q3 | $56K | Sell |
547
-159
| -23% | -$13.7K | ﹤0.01% | 1452 |
|
|
2020
Q2 | $61K | Buy |
706
+125
| +22% | +$9.99K | ﹤0.01% | 1332 |
|
|
2020
Q1 | $33K | Buy |
581
+84
| +17% | +$6.82K | ﹤0.01% | 1416 |
|
|
2019
Q4 | $45K | Buy |
497
+280
| +129% | +$24.6K | ﹤0.01% | 1445 |
|
|
2019
Q3 | $19K | Buy |
217
+15
| +7% | +$1.71K | ﹤0.01% | 1742 |
|
|
2019
Q2 | $23K | Buy |
+202
| New | +$20.4K | ﹤0.01% | 1658 |
|
|
2018
Q4 | – | Sell |
-556
| Closed | -$44K | – | 1201 |
|
|
2018
Q3 | $44K | Sell |
556
-300
| -35% | -$19.6K | ﹤0.01% | 1244 |
|
|
2018
Q2 | $51K | Sell |
856
-100
| -10% | -$5.38K | ﹤0.01% | 1095 |
|
|
2018
Q1 | $38K | Buy |
956
+87
| +10% | +$4.24K | ﹤0.01% | 1098 |
|
|
2017
Q4 | $45K | Buy |
+869
| New | +$46.4K | ﹤0.01% | 864 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Steward Partners Investment Advisory's EXAS Position: Q1 2026 in Review
Steward Partners Investment Advisory sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,070 shares — an estimated $210K sold.
Steward Partners Investment Advisory first reported a position in EXAS in Q4 2017 and held it in 31 quarters. The position peaked at $343K in Q4 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Steward Partners Investment Advisory reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Steward Partners Investment Advisory sold 2,070 Exact Sciences shares in Q1 2026, an estimated $210K.
- Steward Partners Investment Advisory first reported a position in Exact Sciences in Q4 2017 and held it in 31 quarters.
- Steward Partners Investment Advisory's Exact Sciences position peaked at $343K in Q4 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.